As of 2025-06-25, the Intrinsic Value of Morepen Laboratories Ltd (MOREPENLAB.NS) is 34.63 INR. This MOREPENLAB.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 61.89 INR, the upside of Morepen Laboratories Ltd is -44.00%.
The range of the Intrinsic Value is 28.60 - 43.77 INR
Based on its market price of 61.89 INR and our intrinsic valuation, Morepen Laboratories Ltd (MOREPENLAB.NS) is overvalued by 44.00%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 28.60 - 43.77 | 34.63 | -44.0% |
| DCF (Growth 10y) | 40.96 - 62.25 | 49.50 | -20.0% |
| DCF (EBITDA 5y) | 62.05 - 91.13 | 72.82 | 17.7% |
| DCF (EBITDA 10y) | 64.57 - 101.18 | 78.55 | 26.9% |
| Fair Value | 53.85 - 53.85 | 53.85 | -13.00% |
| P/E | 47.26 - 71.95 | 61.19 | -1.1% |
| EV/EBITDA | 31.59 - 67.91 | 45.22 | -26.9% |
| EPV | 10.65 - 13.73 | 12.19 | -80.3% |
| DDM - Stable | 8.52 - 16.63 | 12.58 | -79.7% |
| DDM - Multi | 23.04 - 36.71 | 28.46 | -54.0% |
| Market Cap (mil) | 33,912.62 |
| Beta | 2.00 |
| Outstanding shares (mil) | 547.95 |
| Enterprise Value (mil) | 34,689.77 |
| Market risk premium | 8.31% |
| Cost of Equity | 17.67% |
| Cost of Debt | 5.00% |
| WACC | 17.25% |